Clinical Trial Update: Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olanzapine, netupitant, and palonosetron for controlling nausea and vomiting induced by highly emetogenic chemotherapy in breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Netupitant (netupitant)
• Palonosetron (palonosetron)
• olanzapine (olanzapine)

Snippet

Sponsor: Instituto Brasileiro de Controle do Cancer | Conditions: Nausea Post Chemotherapy | Phase 2 | Status: COMPLETED